SCHEMBL2522352

SCHEMBL2522352

c1ccc2c(c1)Cc1ccc(Nc3ccc4c(c3)-c3ccccc3C4)cc1-2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.56
CYP3A4 P08684 2/20 0.56
HSD17B10 Q99714 2/20 0.54
MAOA P21397 2/20 0.53
ADRA2A P08913 1/20 0.53
SLC6A2 P23975 1/20 0.53
HTR2C P28335 1/20 0.53
SLC6A4 P31645 1/20 0.53
HTR2B P41595 1/20 0.53
PPARG P37231 1/20 0.53
RAB9A P51151 5/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
MAPT P10636 3/20 0.52
NPC1 O15118 3/20 0.52
KDM4E B2RXH2 3/20 0.52
HPGD P15428 2/20 0.52
LMNA P02545 2/20 0.52
ALDH1A1 P00352 1/20 0.52
TDP1 Q9NUW8 1/20 0.46
SRD5A2 P31213 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26322229 0.94 HSD17B10 (0.54) CYP1A2CYP3A4HSD17B10MAOAADRA2A
SCHEMBL2168131 0.92 CYP1A2 (0.66) CYP1A2CYP3A4HSD17B10MAOAADRA2A
SCHEMBL1921953 0.90 CYP1A2 (0.64) CYP1A2CYP3A4HSD17B10MAOAADRA2A
SCHEMBL23561265 0.89 CYP3A4 (0.55) CYP1A2CYP3A4HSD17B10MAOAADRA2A
SCHEMBL19836623 0.89 CYP1A2 (0.50) CYP1A2CYP3A4HSD17B10MAOAADRA2A
SCHEMBL2165580 0.86 CYP1A2 (0.60) CYP1A2CYP3A4HSD17B10MAOAADRA2A
SCHEMBL1921940 0.85 CYP1A2 (0.58) CYP1A2CYP3A4HSD17B10MAOAADRA2A
SCHEMBL20034967 0.84 CYP1A2 (0.54) CYP1A2CYP3A4HSD17B10MAOAADRA2A
Fluorene SCHEMBL5425556 0.82 CYP3A4 (0.60) CYP1A2CYP3A4HSD17B10MAOAADRA2A
SCHEMBL1921956 0.82 CYP1A2 (0.60) CYP1A2CYP3A4HSD17B10MAOAADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039128-B2 Fluorene compound, organic light emitting device and display device using the fluorene compound CANON KABUSHIKI KAISHA (JP) 2011-10-18 US disclosed
US-20100072885-A1 FLUORENE COMPOUND, ORGANIC LIGHT EMITTING DEVICE AND DISPLAY DEVICE USING THE FLUORENE COMPOUND CANON KABUSHIKI KAISHA (JP) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100072885-A1 FLUORENE COMPOUND, ORGANIC LIGHT EMITTING DEVICE AND DISPLAY DEVICE USING THE FLUORENE COMPOUND ARL1, AFF1, AFF2 CYP1A2 214/4885CYP3A4 825/4885HSD17B10 2450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.